Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haolong Lin

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|September 22, 2025
Strategic innovations: Tackling challenges of immunotherapy in acute myeloid leukemiaHaolong Lin, Tao Wang, Jia Wei
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 4, 2024
Antigen escape in CAR-T cell therapy: Mechanisms and overcoming strategiesHaolong Lin, Xiuxiu Yang, Shanwei Ye, et al.
Frontiers in Immunology|October 25, 2021
Advances in Universal CAR-T Cell TherapyHaolong Lin, Jiali Cheng, Wei Mu, et al.
Journal of Translational Medicine|April 8, 2025
Engineering CD5-targeting CAR-NK cells from peripheral blood for the treatment of CD5-positive hematological malignanciesHaolong Lin, Lingfeng Zhang, Tong Ge, et al.
BMC Genomics|August 25, 2020
Features of alternative splicing in stomach adenocarcinoma and their clinical implication: a research based on massive sequencing dataYuanyuan Zhang, Shengling Ma, Qian Niu, et al.
Cancers|May 11, 2024
Adverse Reactions in Relapsed/Refractory B-Cell Lymphoma Administered with Chimeric Antigen Receptor T Cell Alone or in Combination with Autologous Stem Cell TransplantationHaolong Lin, Ting Deng, Lijun Jiang, et al.
Cytotherapy|November 21, 2024
Optimizing the procedure for manufacturing clinical-grade genetically manipulated natural killer cells for adoptive immunotherapyHaolong Lin, Shanwei Ye, Shujia Zhang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 30, 2025
Dnmt1 Alleviates S1PR1-Mediated Pyroptosis after Spinal Cord Injury through Regulating Pon3 ExpressionBirong Peng, Haolong Lin, Mi Zhang, et al.
Cancer Medicine|May 19, 2020
Clinical and immunological features of platelet transfusion refractoriness in young patients with de novo acute myeloid leukemiaXuelian Hu, Haodong Cai, Lu Zheng, et al.
Signal Transduction and Targeted Therapy|March 25, 2022
T cells expressing CD5/CD7 bispecific chimeric antigen receptors with fully human heavy-chain-only domains mitigate tumor antigen escapeZhenyu Dai, Wei Mu, Ya Zhao, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|September 22, 2025
Strategic innovations: Tackling challenges of immunotherapy in acute myeloid leukemiaHaolong Lin, Tao Wang, Jia Wei
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 4, 2024
Antigen escape in CAR-T cell therapy: Mechanisms and overcoming strategiesHaolong Lin, Xiuxiu Yang, Shanwei Ye, et al.
Frontiers in Immunology|October 25, 2021
Advances in Universal CAR-T Cell TherapyHaolong Lin, Jiali Cheng, Wei Mu, et al.
Journal of Translational Medicine|April 8, 2025
Engineering CD5-targeting CAR-NK cells from peripheral blood for the treatment of CD5-positive hematological malignanciesHaolong Lin, Lingfeng Zhang, Tong Ge, et al.
BMC Genomics|August 25, 2020
Features of alternative splicing in stomach adenocarcinoma and their clinical implication: a research based on massive sequencing dataYuanyuan Zhang, Shengling Ma, Qian Niu, et al.
Cancers|May 11, 2024
Adverse Reactions in Relapsed/Refractory B-Cell Lymphoma Administered with Chimeric Antigen Receptor T Cell Alone or in Combination with Autologous Stem Cell TransplantationHaolong Lin, Ting Deng, Lijun Jiang, et al.
Cytotherapy|November 21, 2024
Optimizing the procedure for manufacturing clinical-grade genetically manipulated natural killer cells for adoptive immunotherapyHaolong Lin, Shanwei Ye, Shujia Zhang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 30, 2025
Dnmt1 Alleviates S1PR1-Mediated Pyroptosis after Spinal Cord Injury through Regulating Pon3 ExpressionBirong Peng, Haolong Lin, Mi Zhang, et al.
Cancer Medicine|May 19, 2020
Clinical and immunological features of platelet transfusion refractoriness in young patients with de novo acute myeloid leukemiaXuelian Hu, Haodong Cai, Lu Zheng, et al.
Signal Transduction and Targeted Therapy|March 25, 2022
T cells expressing CD5/CD7 bispecific chimeric antigen receptors with fully human heavy-chain-only domains mitigate tumor antigen escapeZhenyu Dai, Wei Mu, Ya Zhao, et al.
Pageof 2